Structure

Physi-Chem Properties

Molecular Weight:  225.1
Volume:  219.948
LogP:  -0.832
LogD:  0.099
LogS:  -0.031
# Rotatable Bonds:  2
TPSA:  92.95
# H-Bond Aceptor:  5
# H-Bond Donor:  5
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.451
Synthetic Accessibility Score:  3.596
Fsp3:  0.455
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.319
MDCK Permeability:  0.00014656054554507136
Pgp-inhibitor:  0.0
Pgp-substrate:  0.073
Human Intestinal Absorption (HIA):  0.626
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.016

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.328
Plasma Protein Binding (PPB):  22.228410720825195%
Volume Distribution (VD):  1.866
Pgp-substrate:  74.4876937866211%

ADMET: Metabolism

CYP1A2-inhibitor:  0.035
CYP1A2-substrate:  0.072
CYP2C19-inhibitor:  0.024
CYP2C19-substrate:  0.175
CYP2C9-inhibitor:  0.008
CYP2C9-substrate:  0.664
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.406
CYP3A4-inhibitor:  0.01
CYP3A4-substrate:  0.09

ADMET: Excretion

Clearance (CL):  9.502
Half-life (T1/2):  0.546

ADMET: Toxicity

hERG Blockers:  0.043
Human Hepatotoxicity (H-HT):  0.829
Drug-inuced Liver Injury (DILI):  0.202
AMES Toxicity:  0.16
Rat Oral Acute Toxicity:  0.034
Maximum Recommended Daily Dose:  0.018
Skin Sensitization:  0.187
Carcinogencity:  0.596
Eye Corrosion:  0.084
Eye Irritation:  0.236
Respiratory Toxicity:  0.645

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC226944

Natural Product ID:  NPC226944
Common Name*:   BRPXIQPSCKPBLH-NAKRPEOUSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  BRPXIQPSCKPBLH-NAKRPEOUSA-N
Standard InCHI:  InChI=1S/C11H15NO4/c13-5-8-10(15)11(16)9(12-8)6-1-3-7(14)4-2-6/h1-4,8-16H,5H2/p+1/t8-,9-,10-,11-/m0/s1
SMILES:  c1cc(ccc1[C@H]1[C@@H]([C@H]([C@H](CO)[NH2+]1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   10036605
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000218] Pyrrolidines
        • [CHEMONTID:0002336] Phenylpyrrolidines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6890 Euphorbia jolkinii Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22540 Aquilegia vulgaris Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO6890 Euphorbia jolkinii Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2723 Artemisia carvifolia Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO18018 Aster multiradiatus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22540 Aquilegia vulgaris Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14650 Lobelia chinensis Species Campanulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO15952 Adansonia digitata Species Malvaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT497 Individual Protein Maltase-glucoamylase Homo sapiens IC50 = 9300.0 nM PMID[488217]
NPT496 Individual Protein Alpha-L-fucosidase 1 Bos taurus IC50 = 41000.0 nM PMID[488217]
NPT2 Others Unspecified IC50 = 25210.0 nM PMID[488217]
NPT24816 SINGLE PROTEIN Alpha-mannosidase Canavalia ensiformis IC50 = 28000.0 nM PMID[488217]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC226944 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC226944 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data